Replimune Group Inc (NASDAQ:REPL) currently has a daily average trading volume of 1.18M but it saw 1522393 shares traded in last market. With a market cap of 729.24M USD, the company’s current market price of $9.46 came rising about 0.11 while comparing to the previous closing price of $9.45. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.00 and as low as $6.44. In the recent trading on the day, stock has struck highest price mark of $9.23 while lowest mark touched by it was $9.775.
Piper Sandler issued its recommendations for the stock as it resumed the price target for the stock is $44.
Over the week, REPL’s stock price is moving -0.32% down while it is 12.35% when we observe its performance for the past one month. Year-to-date it is 7.99% up and over the past year, the stock is showing a downside performance of -21.88%.
The company is expected to be releasing its next quarterly report on 2025-May-22, for which analysts forecasted an EPS of -0.85 while estimate for next year EPS is -2.86. In next quarter, company is expected to be making quarterly sales of $6.63M as analysts are expecting the sales for current fiscal year at $57.13M and seeing the company making $164.59M in sales next year. Moreover, analysts are in estimates of $1.32M for current-quarter revenue.
Currently, Replimune Group Inc’s total number of outstanding shares is 77.09M with 4.51% of that held by the insiders while 107.45% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -50.67% and return on equity (ROE) at -62.58%. Stock’s beta reads 0.62. Stock has a price to book (P/B) ratio of 1.75. Its return on asset (ROA) is -47.60% on average.
